Brewster, NY, United States of America

Warren R Mikulka



 

Average Co-Inventor Count = 10.8

ph-index = 4

Forward Citations = 193(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Warren R Mikulka: Innovator in Antibody Development

Introduction

Warren R Mikulka is a prominent inventor based in Brewster, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of high-affinity human antibodies. With a total of 6 patents to his name, Mikulka's work has the potential to impact various medical treatments.

Latest Patents

Mikulka's latest patents include innovative methods for creating high-affinity human antibodies to the human IL-4 receptor. One of his notable inventions is an isolated human antibody or antigen-binding fragment that binds to the human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K) of less than 200 pM, as measured by surface plasmon resonance. Additionally, he has developed methods for treating diseases or disorders that can be improved by reducing interleukin-4 (IL-4) activity. These methods involve administering an antibody or antigen-binding fragment that specifically binds to the human IL-4 receptor.

Career Highlights

Mikulka is currently associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Regeneron has allowed him to contribute to groundbreaking research in the field of immunology.

Collaborations

Mikulka has collaborated with notable colleagues, including Sean Stevens and Joel H Martin. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Warren R Mikulka's contributions to the field of biotechnology, particularly in the development of high-affinity antibodies, demonstrate his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the ongoing quest for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…